Seite - (000328) - in Biomedical Chemistry: Current Trends and Developments

Macromolecules, 5(6), 818-819. Milnerwhite, E. J., Ross, B. M., Ismail, R., et al. (1988). One Type of Gamma-Turn, Rather Than the Other Gives Rise to Chain-Reversal in Proteins. Journal of Molecular Biology, 204(3), 777- 782. Motta, A., Reches, M., Pappalardo, L., et al. (2005). The preferred conformation of the tripeptide Ala-Phe-Ala in water is an inverse gamma-turn: Implications for protein folding and drug design. Biochemistry, 44(43), 14170-14178. Nemethy, G., & Printz, M. P. (1972). Gamma-Turn, a Possible Folded Conformation of Polypeptide Chain - Comparison with Beta-Turn. Macromolecules, 5(6), 755- Nyberg, F., Hallberg, A., Hallberg, M., et al. (2010). Application: WO Patent No. 2009- IB530202010004535. Obach, R. S. (1999). Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metabolism and Disposition, 27(11), 1350-1359. Ohsawa, M., Carlsson, A., Asato, M., K et al. (2011). The effect of substance P1-7 amide on nociceptive threshold in diabetic mice. Peptides, 32(1), 93-98. Ohsawa, M., Carlsson, A., Koizumi, T., et al. (2010). Changes of Opioidergic Systems in Diabetic Painful Neuropathy. Paper presented at the INRC 2010, Malmö, Sweden. Okada, Y., Fujita, Y., Motoyama, T., et al. (2003). Structural studies of [2’,6’-dimethyl-L-tyrosine1] endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond. Bioorganic & medicinal chemistry, 11(9), 1983-1994. Olson, G. L., Bolin, D. R., Bonner, M. P., et al. (1993). Concepts and progress in the development of peptide mimetics. Journal of Medicinal Chemistry, 36(21), 3039-3049. Otsuka, M., & Yoshioka, K. (1993). Neurotransmitter functions of mammalian tachykinins. Physiological Reviews, 73(2), 229-308. Piercey, M. F., Dobry, P. J. K., Einspahr, F. J., et al. (1982). Use of Substance-P Fragments to Differentiate Substance-P Receptors of Different Tissues. Regulatory Peptides, 3(5-6), 337- 349. Richardson, J. S. (1981). The anatomy and taxonomy of protein structure. Advances in Protein Chemistry, 34, 167-339. Ripka, A. S., & Rich, D. H. (1998). Peptidomimetic design. Current Opinion in Chemical Biology, 2(4), 441-452. Rizo, J., & Gierasch, L. M. (1992). Constrained peptides: models of bioactive peptides and protein substructures. Annual Review of Biochemistry, 61, 387-418. Rose, G. D., Gierasch, L. M., & Smith, J. A. (1985). Turns in Peptides and Proteins. Advances in Protein Chemistry, 37, 1-109.. (2006). Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT(1) and AT(2) receptors. Journal of Medicinal Chemistry, 49(20), 6133-6137. Rosenström, U., Sköld, C., Lindeberg, G., et al. (2006). Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT(1) and AT(2) receptors. Journal of Medicinal Chemistry, 49(20), 6133-6137. Rubio-Aliaga, I., & Daniel, H. (2002). Mammalian peptide transporters as targets for drug delivery. Trends in Pharmacological Sciences, 23(9), 434-440.